Bispezifische Antikörper: Hoffnungsträger in der Krebsimmuntherapie
Keyword(s):
AbstractNearly seventy years have passed since the first attempts to fuse the antibodies, „magic bullets“ with exquisite target specificity, into multispecific agents that can connect a targeted cell with an effector immune cell. Such efforts have triggered a plethora of engineering advancements to optimize the antigen engagement. Even the most conserved domains of the antibody molecule have been modified to achieve two unique chains pairing, or with an introduction of novel antigen binding sites.
1999 ◽
Vol 96
(5)
◽
pp. 2262-2267
◽
Keyword(s):
Keyword(s):
Keyword(s):
1973 ◽
Vol 137
(2)
◽
pp. 483-493
◽